Reversing the Trend of Declining ROI in Pharma

A new report lays out the ways digital transformation could reverse the trend of declining ROI in pharma R&D.

Tom O’Leary, ICON, Chief Information Officer at ICON outlines a number of factors behind the decline in return on investment (ROI) in this Pharmaphorum article.